- Citations, last 5 years
- 25
- Works, last 5 years
- 20
- h-index
- 25
- Scientists listed
- 5
- Grants since 2016
- 20
Grants received
2023–2025 · research · R44
TempO-LINC high throughput high sensitivity single cell gene expression profiling assay Ph II
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2023–2026 · research · R44
TempO-LINC high throughput high sensitivity single cell gene expression profiling assay Ph II
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2021–2023 · research · R43
TempO-LINC high throughput, high sensitivity single cell gene expression profiling assay
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2021–2022 · research · R43
TempO-Seq assay and cell panel for assessing impact of genetic diversity on compound bioactivity and toxicity risk
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Functional Read-Out Enabling High Compound Throughput Toxicokinetic Assays
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2020–2023 · research · R43
TempO-Vseq Screen for Genomic Risk of CAD Using Blood from a Finger Prick
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2019–2021 · research · R41
High-Throughput Assay for Profiling Alternative Splicing and Splicing Regulators
Kristen W Lynch · Biospyder (United States) · funded by National Institutes of Health
2019–2025 · research · R44
Whole blood filter paper assay for Alzheimers Disease
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2019–2025 · research · R44
Whole blood filter paper assay for Alzheimers Disease
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2019–2025 · research · R44
Whole blood filter paper assay for Alzheimers Disease
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2019–2022 · research · R43
Whole Blood Filter Paper Assay for Alzheimers Disease
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2019–2025 · research · R44
Whole blood filter paper assay for Alzheimers Disease
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2018–2022 · research · R44
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2018–2020 · research · R44
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2018–2023 · research · R44
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2018–2020 · research · R44
TempO-Seq Profiling of RNA Epitranscriptomic Modifications
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2016–2020 · research · R44
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2016–2017 · contract · N43
IGF::OT::IGF SBIR PHASE I TOPIC 353: CFNA TEMPO-SEQ ASSAY
Bruce Seligmann · Biospyder (United States) · funded by National Institutes of Health
2016–2019 · research · R44
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health
2016–2017 · research · R43
TempO-Seq Gene Expression Profiling of Intracellular Stained FACS Sorted Cells
Bruce E. Seligmann · Biospyder (United States) · funded by National Institutes of Health